Mankind Pharma looking to sell 15 per cent stake; PE funds make a bee-line Industry-The Economic Times — September 25, 2017 comments off Mankind Pharma is looking to sell a 15% stake in the company and is eyeing a premium valuation of $500-$600 mn for the same.
Mankind Pharma is looking to sell a 15% stake in the company and is eyeing a premium valuation of $500-$600 mn for the same.